Peptide Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

Publisher : QY Research Reports Publication Date : Mar 12, 2018

Number of Pages : 148 Subcategory : Healthcare
Single User $ 4250
Global User $ 8500

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    Summary

    This report studies the Peptide Therapeutics market status and outlook of global, from angles of players, regions, product types and end industries; this report analyzes the top players in global market, and splits the Peptide Therapeutics market by product type and application/end industries.

    The global Peptide Therapeutics market was XX million US$ in 2017 and is expected to XX million US$ by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

    Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Peptide Therapeutics in these regions, from 2013 to 2025 (forecast), covering
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia and Vietnam))
    South America (Brazil etc.)
    Middle East and Africa (North Africa and GCC Countries)

    The major companies in this report including
    Sanofi
    Teva
    Novo Nordisk
    Takeda
    Eli Lilly
    AstraZeneca
    Novartis
    Shire
    AbbVie
    Ipsen
    Allergan
    Ferring
    Merck
    The Medicines
    Roche
    J & J
    By the product type, the market is primarily split into
    Injection
    Oral
    Other
    By the end users/application, this report covers the following segments
    Cancer
    Metabolic Disorders
    Central Nervous System
    Other

  • Table of Content

    Peptide Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

    Table of Contents

    1 Peptide Therapeutics Market Overview
    1.1 Peptide Therapeutics Product Overview
    1.2 Peptide Therapeutics Market Segment by Type
    1.2.1 Injection
    1.2.2 Oral
    1.2.3 Other
    1.3 Global Peptide Therapeutics Market Size by Type
    1.3.1 Global Peptide Therapeutics Sales and Growth by Type
    1.3.2 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018)
    1.3.3 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
    1.3.4 Global Peptide Therapeutics Price by Type (2013-2018)
    1.4 North America Peptide Therapeutics by Type
    1.5 Europe Peptide Therapeutics by Type
    1.6 Asia-Pacific Peptide Therapeutics by Type
    1.7 South America Peptide Therapeutics by Type
    1.8 Middle East and Africa Peptide Therapeutics by Type

    2 Global Peptide Therapeutics Market Competition by Company
    2.1 Global Peptide Therapeutics Sales and Market Share by Company (2013-2018)
    2.2 Global Peptide Therapeutics Revenue and Share by Company (2013-2018)
    2.3 Global Peptide Therapeutics Price by Company (2013-2018)
    2.4 Global Top Players Peptide Therapeutics Manufacturing Base Distribution, Sales Area, Product Types
    2.5 Peptide Therapeutics Market Competitive Situation and Trends
    2.5.1 Peptide Therapeutics Market Concentration Rate
    2.5.2 Global Peptide Therapeutics Market Share of Top 5 and Top 10 Players
    2.5.3 Mergers & Acquisitions, Expansion

    3 Peptide Therapeutics Company Profiles and Sales Data
    3.1 Sanofi
    3.1.1 Company Basic Information, Manufacturing Base and Competitors
    3.1.2 Peptide Therapeutics Product Category, Application and Specification
    3.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.1.4 Main Business Overview
    3.2 Teva
    3.2.1 Company Basic Information, Manufacturing Base and Competitors
    3.2.2 Peptide Therapeutics Product Category, Application and Specification
    3.2.3 Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.2.4 Main Business Overview
    3.3 Novo Nordisk
    3.3.1 Company Basic Information, Manufacturing Base and Competitors
    3.3.2 Peptide Therapeutics Product Category, Application and Specification
    3.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.3.4 Main Business Overview
    3.4 Takeda
    3.4.1 Company Basic Information, Manufacturing Base and Competitors
    3.4.2 Peptide Therapeutics Product Category, Application and Specification
    3.4.3 Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.4.4 Main Business Overview
    3.5 Eli Lilly
    3.5.1 Company Basic Information, Manufacturing Base and Competitors
    3.5.2 Peptide Therapeutics Product Category, Application and Specification
    3.5.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.5.4 Main Business Overview
    3.6 AstraZeneca
    3.6.1 Company Basic Information, Manufacturing Base and Competitors
    3.6.2 Peptide Therapeutics Product Category, Application and Specification
    3.6.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.6.4 Main Business Overview
    3.7 Novartis
    3.7.1 Company Basic Information, Manufacturing Base and Competitors
    3.7.2 Peptide Therapeutics Product Category, Application and Specification
    3.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.7.4 Main Business Overview
    3.8 Shire
    3.8.1 Company Basic Information, Manufacturing Base and Competitors
    3.8.2 Peptide Therapeutics Product Category, Application and Specification
    3.8.3 Shire Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.8.4 Main Business Overview
    3.9 AbbVie
    3.9.1 Company Basic Information, Manufacturing Base and Competitors
    3.9.2 Peptide Therapeutics Product Category, Application and Specification
    3.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.9.4 Main Business Overview
    3.10 Ipsen
    3.10.1 Company Basic Information, Manufacturing Base and Competitors
    3.10.2 Peptide Therapeutics Product Category, Application and Specification
    3.10.3 Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin(2013-2018)
    3.10.4 Main Business Overview
    3.11 Allergan
    3.12 Ferring
    3.13 Merck
    3.14 The Medicines
    3.15 Roche
    3.16 J & J

    4 Peptide Therapeutics Market Status and Outlook by Regions
    4.1 Global Market Status and Outlook by Regions
    4.1.1 Global Peptide Therapeutics Market Size and CAGR by Regions
    4.1.2 North America
    4.1.3 Asia-Pacific
    4.1.4 Europe
    4.1.5 South America
    4.1.6 Middle East and Africa
    4.2 Global Peptide Therapeutics Sales and Revenue by Regions
    4.2.1 Global Peptide Therapeutics Sales and Market Share by Regions (2013-2018)
    4.2.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2013-2018)
    4.2.3 Global Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
    4.3 North America Peptide Therapeutics Sales, Revenue, Price and Gross Margin
    4.3.1 United States
    4.3.2 Canada
    4.3.3 Mexico
    4.4 Europe Peptide Therapeutics Sales, Revenue, Price and Gross Margin
    4.4.1 Germany
    4.4.2 UK
    4.4.3 France
    4.4.4 Italy
    4.4.5 Russia
    4.4.6 Turkey
    4.5 Asia-Pacific Peptide Therapeutics Sales, Revenue, Price and Gross Margin
    4.5.1 China
    4.5.2 Japan
    4.5.3 Korea
    4.5.4 Southeast Asia
    4.5.4.1 Indonesia
    4.5.4.2 Thailand
    4.5.4.3 Malaysia
    4.5.4.4 Philippines
    4.5.4.5 Vietnam
    4.5.5 India
    4.5.6 Australia
    4.6 South America Peptide Therapeutics Sales, Revenue, Price and Gross Margin
    4.6.1 Brazil
    4.7 Middle East and Africa Peptide Therapeutics Sales, Revenue, Price and Gross Margin
    4.7.1 North Africa
    4.7.2 GCC Countries

    5 Peptide Therapeutics Application/End Users
    5.1 Peptide Therapeutics Segment by Application
    5.1.1 Cancer
    5.1.2 Metabolic Disorders
    5.1.3 Central Nervous System
    5.1.4 Other
    5.2 Global Peptide Therapeutics Product Segment by Application
    5.2.1 Global Peptide Therapeutics Sales by Application
    5.2.2 Global Peptide Therapeutics Sales and Market Share by Application (2013-2018)
    5.3 North America Peptide Therapeutics by Application
    5.4 Europe Peptide Therapeutics by Application
    5.5 Asia-Pacific Peptide Therapeutics by Application
    5.6 South America Peptide Therapeutics by Application
    5.7 Middle East and Africa Peptide Therapeutics by Application

    6 Global Peptide Therapeutics Market Forecast
    6.1 Global Peptide Therapeutics Sales, Revenue Forecast (2018-2025)
    6.1.1 Global Peptide Therapeutics Sales and Growth Rate Forecast (2018-2025)
    6.1.1 Global Peptide Therapeutics Revenue and Growth Rate Forecast (2018-2025)
    6.2 Global Peptide Therapeutics Forecast by Regions
    6.2.1 North America Peptide Therapeutics Sales and Revenue Forecast (2018-2025)
    6.2.2 Europe Peptide Therapeutics Sales and Revenue Forecast (2018-2025)
    6.2.3 Asia-Pacific Peptide Therapeutics Sales and Revenue Forecast (2018-2025)
    6.2.3.1 China
    6.2.3.2 Japan
    6.2.3.3 Korea
    6.2.3.4 Southeast Asia
    6.2.3.5 India
    6.2.3.6 Australia
    6.2.4 South America Peptide Therapeutics Sales and Revenue Forecast (2018-2025)
    6.2.5 Middle East and Africa Peptide Therapeutics Sales and Revenue Forecast (2018-2025)
    6.2.5.1 North Africa
    6.2.5.2 GCC Countries
    6.3 Peptide Therapeutics Forecast by Type
    6.3.1 Global Peptide Therapeutics Sales and Revenue Forecast by Type (2018-2025)
    6.3.2 Injection Gowth Forecast
    6.3.3 Oral Gowth Forecast
    6.4 Peptide Therapeutics Forecast by Application
    6.4.1 Global Peptide Therapeutics Sales Forecast by Application (2018-2025)
    6.4.2 Global Peptide Therapeutics Forecast in Cancer
    6.4.3 Global Peptide Therapeutics Forecast in Metabolic Disorders

    7 Peptide Therapeutics Upstream Raw Materials
    7.1 Peptide Therapeutics Key Raw Materials
    7.1.1 Key Raw Materials
    7.1.2 Key Raw Materials Price
    7.1.3 Raw Materials Key Suppliers
    7.2 Manufacturing Cost Structure
    7.2.1 Raw Materials
    7.2.2 Labor Cost
    7.2.3 Manufacturing Expenses
    7.3 Peptide Therapeutics Industrial Chain Analysis

    8 Marketing Strategy Analysis, Distributors
    8.1 Marketing Channel
    8.1.1 Direct Marketing
    8.1.2 Indirect Marketing
    8.1.3 Marketing Channel Development Trend
    8.2 Distributors
    8.3 Downstream Customers

    9 Research Findings and Conclusion

    Appendix
    Methodology/Research Approach
    Research Programs/Design
    Market Size Estimation
    Market Breakdown and Data Triangulation
    Data Source
    Secondary Sources
    Primary Sources
    Disclaimer

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.